The anti-inflammatory and antiapoptotic heme degrading enzyme heme oxygenase-1 (HO-1) has been shown recently to interfere with replication of hepatitis C virus (HCV). We investigated the effect of HO-1 products carbon monoxide (CO), iron and biliverdin on HCV replication using the replicon cell lines Huh-5-15 and LucUbiNeo-ET, stably expressing HCV proteins NS3 through NS5B. Incubation of these cell lines in the presence of the CO donor methylene chloride transiently reduced HCV replication, whereas an increase of iron in cell culture by administration of The heme-degrading enzyme heme oxygenase-1 (HO-1) exerts anti-inflammatory and antiapoptotic effects in vitro and in vivo. Induction or overexpression of HO-1 protects kidneys from acute ischemic failure 6 or ischemia-reperfusion injury, 7 cardiac xenografts from rejection, 8 and livers from ischemia-reperfusion injury caused by either transplantation 9 or hemorrhage/resuscitation, 10 as well as from apoptotic damage. 11 Degradation of heme by heme oxygenases results in the production of carbon monoxide (CO), free iron, and biliverdin. HO-1, in contrast to the isoforms HO-2 and HO-3, is inducible by various stimuli, 12,13 such as cobalt-protoporphyrin-IX (CoPP), 14,15 but also by hypoxia, which can be induced by, for example, high amounts of CO. 16 Of the HO-1 products, CO and biliverdin seem to be the major mediators of protective HO-1 effects within the liver. 17-19 CO application in vitro or in vivo can be achieved by special